| Accession Number: | 0001104659-21-029183 |
| Date: | 2021-02-24 |
| Issuer: | ACURA PHARMACEUTICALS, INC (ACUR) |
| Original Submission Date: |
CLEMENS PETER A
C/O ACURA PHARMACEUTICALS, INC.
616 N. NORTH COURT, SUITE 120
PALATINE, IL 60067
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2021-02-24 | M | 40,000 | a | $0.15 | 431,197 | direct | ||
| COMMON STOCK | 2021-02-24 | F | 15,100 | d | $0.40 | 416,097 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STOCK OPTIONS | 0.151 | 2021-02-24 | deemed execution date | M | 40,000 (d) | 2019-12-11 | 2023-12-11 | common stock 40,000 | $0.15 | 0 | direct |
| ID | footnote |
|---|---|
| f1 | represents payment for exercise price. |
| f2 | exercise price is closing price of issuer's common stock on december 11, 2018. |
| f3 | awarded under the acura pharmaceuticals inc. 2016 stock option plan |
| f4 | 100% of the shares underlying the options vest and are exercisable after one year on december 11, 2019 |
| f5 | not applicable. |
